STAT3 and rhabdomyosarcoma: In this study, we found that AZD1480-mediated inhibition of the JAK/STAT3 pathway resulted in in vitro and in vivo suppression of tumor growth in neuroblastoma, rhabdomyosarcoma and Ewing sarcoma.